Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Our resources section is designed to be a toolkit supporting every step of your healthcare journey.
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care
Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches
Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Empower patients with PsA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
Empower patients with axSpA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
GL-DA-2600607
Date of preparation: November 2023